Drug Trial Radar · NCT00696631
European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure
Last checked: Nov 19, 2026Latest source record: Feb 15, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
653
Actual
Start
Jun 2002
Primary completion
Jan 2003
Study completion Aug 2003
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 13, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the efficacy, tolerability and safety of dronedarone versus placebo in patients with symptomatic congestive heart failure (CHF) and left ventricular dysfunction (LVD) when added to evidence based treatments for CHF.
Conditions
- Congestive Heart Failure
Interventions
Dronedarone (SR33589)Drug
oral administration
PlaceboDrug
oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Death from any cause or adjudicated hospitalization for worsening heart failureTime frame: Until study cut-off date
Locations
6 sites in 6 countries. Site status is shown where the registry gives one.
Sanofi-aventis Administrative Office
Hørsholm, Denmark
Sanofi-aventis Administrative Office
Budapest, Hungary
Sanofi-aventis Administrative Office
Gouda, Netherlands
Sanofi-aventis Administrative Office
Lysaker, Norway
Sanofi-aventis Administrative Office
Warsaw, Poland
Sanofi-aventis Administrative Office
Bromma, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.